Skip to main content
Home
  • Main Menu
  • Topics
    • Video
    • Provider
    • Payer
    • Pharma
    • Consumer
    • Investor

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition
Global Edition

FDA announces eight winners of opioid epidemic innovation challenge

The eight devices will receive increased guidance and interaction for their clearance efforts, and some will receive Breakthrough Device designation.
By Jonah Comstock
December 03, 2018
04:00 pm
Share

The FDA has announced the winners of the opioid addiction innovation challenge the agency launched last May. Out of more than 250 applications from medical device developers, the FDA selected eight winners. 

"While these products will not automatically receive marketing authorization from the FDA, the device developers will receive increased interaction with CDRH experts, guidance for clinical trial development plans, and expedited review," Drs. Jeffrey Shuren and Jonathan Jarow, director and chief medical officer respectively of the FDA's Center for Devices and Radiological Health, wrote in a blog post announcing the winners.

"Breakthrough Device designation will be granted to those devices selected in the Challenge that meet the statutory criteria for designation upon request by the sponsor," Shuren and Jarow continued. "In most cases, applicants will eventually submit one or more formal applications to the FDA, such as an Investigational Device Exemption, De Novo request, 510(k) premarket notification, or Premarket Approval. The review of these applications will be expedited to minimize review times, however, patient safety is our number one priority and all product applicants will still be held to the FDA’s gold standard and required to meet the applicable standard of safety and effectiveness."

The eight devices that won the challenge are:

  • Brainsway, an Israeli company developing Deep Transcranial Magnetic Stimulation devices, currently for depression and OCD.
  • Georgia-based medical device company Avanos, which has developed a pain therapy device.
  • iPill Dispenser, a company working on smart pill bottles to prevent overdosing or sharing of opioids using security measures like fingerprint biometrics.
  • Pulse oximetry giant Masimo, which submitted an overdose detection device.
  • Wound compression therapy company ThermoTek, which offers non-opioid pain treatment alternatives for certain patients.
  • Actuarial consultancy company Milliman, which submitted a system for predicting opioid overprescription.
  • Algomet Rx, a stealthy startup working on a product called "Rapid Drug Screen."
  • CognifiSense, a company working on virtual reality treatments for chronic pain.

Why it matters

Opioids were responsible for more than 70,000 deaths in 2017, up from 40,000 in 2016. The combination of overprescription and insufficient treatment resources have led to a rising epidemic that disproportionately affects midwestern and rural America. The FDA believes that novel technologies can help to address the crisis. 

"Medical devices, including digital health devices like mobile medical apps, have the potential to play a unique and important role in tackling the opioid crisis,” FDA Commissioner Dr. Scott Gottlieb said when he announced the challenge in May. “We must advance new ways to find tools to help address the human and financial toll of opioid addiction.”

What's the trend?

In many ways the opioid crisis has become the signature medical issue of the Trump administration, with initiatives to fight the epidemic arising in an HHS code-a-thon, a CDC blockchain pilot with IBM, rare bipartisan legislation to improve telemedicine and e-prescribing resources, and more.

The FDA itself, meanwhile, has recently approved at least two novel devices aimed at addressing opioid abuse: a wearable auricular neurostimulation device from DeAnsys designed to treat symptoms of opioid withdrawal, and reSET-O, a digital therapeutic for opioid use disorder from Pear Therapeutics that received an Expedited Access Pathway (EAP) designation from the FDA last year. Pear Therapeutics is also a part of the agency's Pre-Cert pilot program.

Tags: 
FDA, opioid epidemic, opioids, opioid addiction, Brainsway, Avanos, iPill Dispenser, Masimo, ThermoTek, Milliman, Algomet Rx, CognifiSense

More regional news

Pharmacist interacting online

Serve You Rx, Amazon Pharmacy partner for home delivery

By
Anthony Vecchione
May 02, 2025
Two people shaking hands with six others watch

DarioHealth closes up to $50M debt refinancing and more funding news

By
Jessica Hagen
May 02, 2025
Smart phone and smart watch

Oura and Google Fitbit partner with academia and others to battle opioid disorder

By
Anthony Vecchione
May 02, 2025
Share

Top Story

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder

Editor's Pick

23andMe files for bankruptcy, CEO Wojcicki resigns
Q&A: Oura appoints its first chief medical officer
First blood pressure management system integrated with DeepSeek in Hong Kong
Emirates will offer inflight telemedicine aboard 300 aircraft
Nanowear announces partnership with Dexcom
Navina raises $55M to expand AI for value-based care

More Stories

Pharmacist interacting online
Serve You Rx, Amazon Pharmacy partner for home delivery
Two people shaking hands with six others watch
DarioHealth closes up to $50M debt refinancing and more funding news
Nurse consulting with patient
Teton unveils 3D hospital digital twin using Denmark's supercomputer
Young person communicating with a cell phone
Talkspace, Bark Technologies partner to monitor children's online activities
Pharmacist giving a person an injection
Plenful scores $50M and more funding news
Person interacting with a healthcare professional via tablet
Teladoc acquires UpLift for $30M, releases first quarter results
Person in a pharmacy setting
Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy
Healthcare professional looking at a PC screen
Commure, HealthTap partner for expanded after-hours care
Home

More News

  • Healthcare IT News
  • Healthcare IT News Australia
  • Healthcare Finance News
  • HIMSS TV

MobiHealthNews

 

Connect

Add MobiHealthNews to your network.
HIMSS25 European Health Conference & Exhibition
HIMSS25 European Health Conference & Exhibition
Get ready for knowledge-sharing, all the latest innovations, and in-depth demos with Europe's most influential healthcare community.
10 - 12 June, 2025 | Paris
Learn More
AI in Healthcare Forum
AI in Healthcare Forum
The HIMSS AI in Healthcare Forum cuts through the hype to showcase real-world examples illustrating the transformative potential, and realistic challenges of AI application across the care continuum.
10 - 11 July 2025 | New York
Learn More

Footer Menu

  • About
  • Advertise
  • Reprints
  • Contact
  • Privacy Policy

© 2025 MobiHealthNews is a publication of HIMSS Media

X

Topics

  • Video
  • Provider
  • Payer
  • Pharma
  • Consumer
  • Investor

Career

  • Events
  • Jobs
  • Learning Center

More

  • About
  • Advertise
  • Contact
  • Privacy Policy

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Search form

Top Stories

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder
Three surgeons operating on a patient
Thyroid cancer AI assistant developed in Hong Kong
A doctor discussing findings with an older patient
Digital dementia support project gets $2M federal funding and more briefs